Embecta Corp. /
Owen Mumford Holdings Limited
Embecta Corp. completes purchase of Owen Mumford Holdings Limited




Source for the buyer and target: Embecta Corp.
For the buyer and target.
“Embecta Corp. ("embecta") (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings Limited ("Owen Mumford"), a privately held, UK-based innovator and manufacturer of medical devices and drug delivery technologies.”
Published 15 May 2026
Open the sourceWhat happened
Embecta Corp. finished its acquisition of Owen Mumford Holdings Limited on May 15, 2026. Owen Mumford is a privately held, UK-based maker of medical devices and drug delivery technologies. [01]
The deal carries an upfront cash payment of £100 million at closing, subject to customary adjustments. Up to an additional £50 million could follow if commercial milestones tied to sales of the Aidaptus® auto-injector platform are met through June 30, 2029. [01]
Embecta says the deal moves it toward becoming a broad-based medical supplies company that provides drug delivery platforms to pharmaceutical companies. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Embecta Corp. completes purchase of Owen Mumford Holdings Limited
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
“Embecta Corp. completes purchase of Owen Mumford Holdings Limited Embecta Corp. finished its acquisition of Owen Mumford Holdings Limited on May 15, 2026”
Open the sourceDeadline
“Up to an additional £50 million could follow if commercial milestones tied to sales of the Aidaptus® auto-injector platform are met through June 30, 2029”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly